Medmix, headquartered in Switzerland (CH), operates within the Other Business Services sector, specifically focusing on advanced delivery systems and application solutions. Founded in 2021, the company has quickly established itself as a leader in the field, leveraging innovative technologies to enhance product performance and user experience.
With a strong presence in Europe, North America, and Asia, Medmix offers a diverse range of core products, including precision dispensing systems and customised application solutions. These offerings are distinguished by their reliability and efficiency, catering to various industries such as healthcare, consumer goods, and industrial applications.
Recognised for its commitment to quality and innovation, Medmix has achieved significant milestones in a short span, positioning itself as a trusted partner for businesses seeking cutting-edge solutions in the dynamic landscape of business services.
+25 vs industry average
Medmix’s score of 57 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Medmix?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Business Services has below-average carbon intensity
Industry performance
The Business Services industry has increased its overall emissions by 24% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Medmix's reported carbon emissions
Medmix, a company in the "Other business services (74)" sector headquartered in Switzerland, reported total greenhouse gas emissions of approximately 73.5 billion kg CO2e in 2024. This figure encompasses Scope 1, 2, and 3 emissions. In the preceding year, 2023, the total emissions were approximately 67.6 billion kg CO2e, and in 2022, they were approximately 74.8 billion kg CO2e. The company has established a significant climate commitment: to achieve a 50% reduction in absolute CO2 carbon footprint by 2030, using 2019 as the baseline year. Furthermore, Medmix has committed to a near-term target of reducing absolute Scope 1 and 2 GHG emissions by 80% by 2029, also from a 2019 baseline. Alongside this, they aim to reduce absolute Scope 3 GHG emissions by 42% within the same timeframe, covering categories such as purchased goods and services, capital goods, fuel and energy-related activities, upstream transportation and distribution, waste generated in operations, business travel, and employee commuting. Looking further ahead, Medmix has a long-term net-zero target for 2050, aiming to reduce absolute Scope 1, 2, and 3 GHG emissions by 90% from the 2019 baseline. These targets align with keeping global warming to 1.5°C.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Medmix’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Medmix yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Medmix’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project